Meetings to be held in Denver on April 17 and in Chicago on April 18 hosted by Oppenheimer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FUSN:
- Fusion announces presentation of data from Phase 2 TATCIST clinical trial
- What the Fusion Pharmaceuticals (NASDAQ:FUSN) Acquisition Means for Investors
- Largest borrow rate increases among liquid names
- Fusion Pharmaceuticals Accelerates Oncology Pipeline
- Fusion Pharmaceuticals reports Q4 EPS (39c), consensus (34c)
Questions or Comments about the article? Write to editor@tipranks.com